fda glp-1 warning letters november 2025 Alert: Endocrinology Drug Recalls and Approvals FDA issued 30 warning letters

Understanding Lean Muscle Mass Lean muscle mass isnt just about aesthetics or physical strength

Christopher McGowan, gastroenterologist and obesity medicine specialist at Everself, a medical provider that specializes in obesity management

This isnt the usual take it and hope experience that most supplements offer

Which GLP-1 (Glucagon-like peptide-1) receptor agonist is most likely to be covered by Blue Cross Blue Shield (BCBS)?

Together they: Run blood tests and optimise iron, vitamin D and B12 Stabilise calorie intake at a safer, sustainable level Recommend a scalp-focused regime with a hair growth shampoo, conditioner and scalp elixir designed for thinning hair (such as the Watermans system) Over the following 69 months, shedding slows, texture improves, and new baby hairs appear at the hairline while the metabolic benefits of weight loss are maintained under medical supervision

This article aims to provide an overview of GLP-1 based drugs, focusing on semaglutide (marketed as Ozempic for type 2 diabetes and as Wegovy for obesity) and tirzepatide (marketed as Mounjaro), which is a dual GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 agonist